StockTipsArenaBeta

BUY Cohance Lifesciences Limited — Arun Kumar Mantri

BUYCohance Lifesciences Limited
Cohance Lifesciences share price target & all analyst calls

byArun Kumar MantriHorizon: NA (inferred Swing (≤2wk))21 Oct 2026via CNBC Awaaz.

Entry₹468.45Inferred
Target₹495
Total upside +5.67%
Stop loss₹456-2.66% risk
CMP₹461.812h ago
Active-1.42%+7.19%upside left 12d left
Follow Arun Kumar Mantri for new calls(24% target hit, 188 closed calls)Get alertsWatch COHANCE for new buy/sell callsGet alertsSee 104 other Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 22 Oct, 4:44 am IST
2 supporting2 neutral0 opposing
Supports the BUY call (2)

MACD above its signal line — bullish momentum

Technicals · macd·21 Oct · today

1 advisor has an active short-term BUY call on this stock

Advisor consensus · adjacent horizon·18 Aug · 2mo ago

Neutral / worth noting (2)

Mr. Abhimanyu Ojha has been appointed as the Chief Financial Officer of the company.

BSE · Company Update·9 Oct · 2w ago

(opens in new tab)

Mr. Abhimanyu Ojha has been appointed as the Chief Financial Officer of the company effective October 12, 2026.

NSE · Appointment·9 Oct · 2w ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Cohance Lifesciences

All analyst calls on Cohance Lifesciences

More from Arun Kumar Mantri

Every call and its outcome